Digital Secondary Prevention in Cardiovascular Disease

Status Not yet recruiting

Clinical Trial Summary

Although advances in knowledge of the prevention, diagnosis and treatment of atherothrombosis are encouraging, cardiovascular diseases (CVD), with acute and chronic ischemic heart disease in particular, remain a major cause of disability and premature death throughout the world. Cardiac rehabilitation (CR) and secondary prevention are coordinated multidimensional evidence-based strategies that aim to assist patients with acute and chronic ischemic heart disease return to an active and satisfying life and to prevent the recurrence of further cardiac events. Since CR is time limited after an acute event, secondary prevention proposes a continuum where care is provided for the rest of a person's life according to the existence of cardiovascular risk factors. Secondary prophylaxis is fundamental for the recovery of the patient, but in most cases, it is only insufficiently implemented. To ensure adequate resources for the delivery of health care and to further improve the level of care, care-delivery models need to be changed in a way that patients themselves become more involved in their own care. Mobile health (mHealth) is a rapidly growing health delivery methodology with the potential to impact on health care research, health care delivery and health outcomes. Therefore, the aim of the study is to determine the impact of plaque visualization using a digital intervention on treatment adherence to improve the cardiovascular risk profile. Participants will be randomized into two groups: intervention group and control group. Participants of the control group receive the best medical care according to current guideline recommendations without access to the app. Participants of the intervention group receive the best medical care according to current guideline recommendations with full access to the Smartphone application at time of study begin until the completion of the follow-up period of 12 months. The access to the app includes access to relevant findings including ultrasound images of the carotid artery, lipid profile, blood pressure values, and weight.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05096637
Study type	Interventional
Source	University Hospital, Essen
Contact
Status	Not yet recruiting
Phase	N/A
Start date	November 2021
Completion date	July 2023

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT03630835` - 99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques	Phase 2/Phase 3
Enrolling by invitation	`NCT06194526` - Whole Blood Transcriptomic Signal According to Coronary Atherosclerotic Plaque Burden Assessed by CT Angiography
Recruiting	`NCT05821894` - Carotid Plaque Imaging Project (CPIP)
Recruiting	`NCT05438121` - STabilization of Atheroma By Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)
Completed	`NCT05619042` - Detection of Coronary Artery Calcifications by Whole Blood Transcriptome Analyzed by Artificial InTelligence Algorithms
Completed	`NCT02607748` - 18F-fluoride (18F-NaF) PET for Identifying Coronary Atherosclerotic Plaques	Phase 4
Completed	`NCT01873716` - Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque	Phase 1
Completed	`NCT02649881` - Diagnosis of Macrophage Coronary Plaque by Optical Tomographic Imaging
Recruiting	`NCT05156736` - Pakistan Study of Premature Coronary Atherosclerosis in Young Adults
Recruiting	`NCT04185493` - Coronary Artery Geometry and the Severity of Coronary Atherosclerosis
Completed	`NCT03141580` - Long-term Follow-up NIRS-IVUS Imaging of Pre-existing Carotid Stents	N/A
Terminated	`NCT04267094` - Reduced Radiation Dose and IR-impact on Coronary Calcium Quantification	N/A
Completed	`NCT03962686` - Molecular Mechanisms and Carotid Atherosclerosis
Completed	`NCT04835467` - First-In-Human Intracoronary OCT-FLIm In Patients Undergoing PCI	N/A
Not yet recruiting	`NCT06080256` - Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.